NCT06850870Active, not recruitingPhase 1
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
Onward Door-Through-Door Companion Rideshare Technology to Improve Care for Older Adults and Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
Source: ClinicalTrials.gov · Last updated 21 Jul 2026
Brief summary (registry, in English)
The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is: Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services?
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 17 Feb 2025
- Start date
- 29 Aug 2025
- Primary completion date
- 28 Dec 2026
- Lead sponsor
- Onward Health, Inc
- Diseases
- Alzheimer disease
- NCT number
- NCT06850870
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 120
- From 29 Aug 2025 to the primary completion date, 28 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- current enrollment in another transportation study;
- already using any type of free or heavily subsized transportation service;
- enrollees with comfort care only;
- Not wheelchair bound, e.g. if using a wheelchair must be foldable and must be able to transfer
- Transient, lacking consistent long term housing
- Resides outside of the San Francisco Bay Area
Who the study is looking for
- All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation;
- have scheduled medical appointments at partner practices of Onward;
- ages 60+
- community-dwelling;
- 60 participants who self-reported cognitive problems, such as memory issue, or have mild cognitive impairment, subjective cognitive decline, or AD/ADRD diagnosis
- Resides and attends appointments in the following San Francisco Bay Area Counties (San Francisco, Alameda, Contra Costa, Marin, San Mateo, Sonoma)
Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Onward Health HQ Coordinator of this site? Confirm its status | San Leandro | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.